Global Expansion Opportunities HRA Pharma has a presence in 11 European countries and partnerships in over 71 countries worldwide. Leveraging these existing networks can open up opportunities for global sales expansion and market penetration.

Innovative Product Portfolio With a focus on innovative Rx-to-OTC switches and a range of products addressing unmet customer needs, HRA Pharma's product portfolio presents opportunities for sales growth through differentiation and meeting evolving consumer demands.

Partnership Development Strategic partnerships with companies like Myhermes and acquisitions like Merz provide avenues for sales collaboration, cross-promotion, and access to new markets, offering potential sales opportunities through collaborative efforts.

Business Development with Newly Acquired Brands Acquisitions such as Perrigo Company plc and Opill present opportunities for cross-selling products and leveraging synergies to enhance sales figures and market presence, tapping into the newly acquired brands' customer base.

Research Collaboration & FDA Approval Collaborations with research organizations like Ibis Reproductive Health to develop OTC birth control pills and seeking FDA approval indicate a commitment to product innovation. Leveraging this research can lead to sales opportunities in emerging markets and consumer segments.